                </a></li></ul></div><p><strong>Figure 1.  <span><em> C. albicans</em> produces a tri-hydroxy derivative of EPA that is structurally identical to the human anti-inflammatory lipid mediator RvE1.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>The MS/MS spectra of biogenic RvE1 (1A) and 18-HEPE (1B) produced by <em>C. albicans</em> cultured in liquid media supplemented with EPA. (1C) <em>C. albicans</em>, cultured in the presence of EPA the LO inhibitors esculetin or zileuton (100 ÂµM) as well as the CYP450 inhibitor, 17-ODA, reduced RvE1 biosynthesis (squares). LO inhibitors, but not the CYP450 inhibitor, reduced biosynthesis of 5-HEPE (circles), 12-HEPE (diamonds), and 18-HEPE (triangles).</p>
